Interactions between Bioactive Diperoxovanadate Complexes and Imidazole： Insights into Their Solution Structures by NMR and ESI-MS

1 INTRODUCTION As a required metal for some enzymes such as haloperidases and nitrogenases, vanadium com- pounds are capable of having many biological acti- vities. Similar to inorganic phosphates, vanadium compounds activate the functions of a numb…     

含有机配体的活性双过氧钒配合物与组氨酸的相互作用研究

在合成和表征了4种具有较强生物活性双过氧钒配合物K_3[VO(O_2)_2(ox)]· 2H_2O，Na[VO(O_2)_2(bipy)]·5H_2O，K[VO(O_2)_2(phen)]·3H_2O和K_2[VO (O_2)_2(pic)]·2H_2O[分别缩写为pV(ox)，pV(bipy)，pV(phen)和pV(pic)，其中 ox为草酸根，bipy为2,2'-联吡啶，phen为邻菲咯啉，pic为2-羧酸吡啶负离子]的 基础上，利用多种NMR技术和电喷雾质谱（ESI-MS）研究了这4种含有机配体双过氧 钒酸合物与组氨酸（His）在溶液中的相互作用以及反应物浓度、时间、pH等对相 互作用体系的影响。~(51)V NMR跟踪监测的结果表明：双过氧钒配合物pV(ox)和 pV(pic)与His在中性水溶液中存在强配位相互作用，而pV(bipy)和pV(phen)与His 在中性水溶液中无明显作用。我们还利用谱学方法确定了pV(ox)和His相互作用后 所生成产物是pV(ox)分别与His在中性水溶液中无明显作用。我们还利用谱学方法 确定了pV(ox)和His相互作用后所生成产物是pV(ox)分别与His咪唑基上的3-N和1- N配位的一对异构体。     

NMR研究N-甲基咪唑与双过氧钒配合物的相互作用

为探讨过氧钒配合物上有机配体对反应平衡的影响, 在模拟生理条件下(0.15 mol/L NaCl溶液), 应用多核(¹H, ¹³C和⁵¹V)多维(COSY) NMR以及变温技术等谱学方法研究双过氧钒配合物[OV(O₂)₂LL']ⁿ− [n＝1～3, LL'＝oxalate (缩写为oxa)、picolinate(缩写为pic)、bipyridine(缩写为bipy)和1,10-phenanthroline(缩写为phen), 与它们配位的含钒物种分别缩写为bpV(oxa), bpV(pic), bpV(bipy)和bpV(phen)]与N-甲基咪唑(缩写为N-Me-Im)的相互作用, 实验结果表明N-Me-Im与4种双过氧钒配合物的反应活性从强到弱的顺序为: bpV(oxa)＞bpV(pic)＞bpV(bipy)＞bpV(phen). 研究表明金属中心上配体的配位能力和空间位阻都对反应平衡产生较大的影响, 同时竞争配位的结果导致新的过氧物种[OV(O₂)₂(N-Me-Im)]⁻的生成, 而利用上述谱学方法则有助于揭示此类相互作用体系的反应过程和配位方式.     

双过氧钒配合物与N-乙基咪唑相互作用的NMR研究

为探讨过氧钒配合物中有机配体对反应平衡的影响, 在模拟生理条件下(0.15 mol·L-1 NaCl 溶液), 应用多核(1H、13C 和51V)多维(COSY 和HSQC)核磁共振(NMR)以及变温技术等谱学方法研究双过氧钒配合物[OV(O2)2L]-(L=D2O 或HOD, 与之配位的过氧钒物种简写为bpV)和[OV(O2)2LL']n-｛n=1-2, LL'=3-羟基-皮考啉酸根(3-OH-pic), 2-(2'-吡啶)-咪唑(py-im), 1,10-邻菲啰啉(phen), 与它们配位的含钒物种分别简写为bpV(3-OH-pic)、bpV(py-im)和bpV(phen)｝与N-乙基咪唑(N-Et-im)的相互作用. 实验结果表明, N-Et-im 与4种双过氧钒配合物反应性从强到弱的顺序为bpV>bpV(3-OH-pic)>bpV(py-im)>bpV(phen). 研究表明, 金属中心上配体的配位能力、空间位阻和分子量等因素都对反应平衡产生较大的影响,同时竞争配位的结果导致新的6配位过氧物种[OV(O2)2(N-Et-im)]-的生成.利用上述谱学方法有助于揭示此类相互作用体系的反应过程和配位方式.     

Racemic monoperoxovanadium(V) complexes with achiral OO and ON donor set heteroligands: synthesis, crystal structure and stereochemistry of [NH3(CH2)2NH3][VO(O2)(ox)(pic)].2H2O and [NH3(CH2)2NH3][VO(O2)(ox)(pca)

Monoperoxovanadium(V) complexes, [NH3(CH2)2NH3][VO(O2)(ox)(pic)].2H2O (1) and [NH3(CH2)2NH3][VO(O2)(ox)(pca)] (2) [NH3(CH2)2NH3 = ethane-1,2-diammonium(2+), ox=oxalate(2-), pic=pyridine-2-carboxylate(1-), pca=pyrazine-2-carboxylate(1-)], were synthesized and characterized by X-ray analysis, IR and Raman spectroscopies. The five equatorial positions of the pentagonal bipyramid around the vanadium atoms are occupied by the eta2-peroxo ligand, two oxygen atoms of the ox, and the nitrogen atom of the pic or pca ligands, respectively. The oxo ligand and the oxygen atom of pic or pca are in the axial positions. Networks of X-HO (X=C, N or O) hydrogen bonds, and pi-pi interactions between aromatic rings in and anion-pi interactions in , determine the molecular packings and build up the supramolecular architecture. Three stereochemical rules for occupation of the donor sites in two-heteroligand [VO(O2)(L1)(L2)] complexes (L1, L2 are bidentate neutral or differently charged anionic heteroligands providing an OO, NN or ON donor set) are discussed. and crystallize as racemic compounds. The 51V NMR spectra proved that the parent complex anions of and partially decompose on dissolution in water to the monoperoxo-ox, -pic or -pca complexes.     

NMR and theoretical investigations on the structures and dynamics of octahedral bis(chelate)dichloro V(III) compounds isolated by an unusual reduction of non-oxo V(IV) species

Reaction of the non-oxo V(IV) species [V(IV)Cl(2)(L(OO))(2)] [L(OO) = acetylacetonate (acac(-)) or benzoylacetonate (bzac(-))] with a chelate nitrogen-donor ligand L(NN) in acetonitrile leads to the reduction of V(IV) to V(III) and the formation of the mononuclear V(III) compounds of the general formula [V(III)Cl(2)(L(OO))(L(NN))] (L(OO) and L(NN) are acac(-) and bipy for 1; acac- and 5,5'-me(2)bipy for 2; acac(-) and 4,4'-tb(2)bipy for 3; acac(-) and phen for 4; bzac(-) and bipy for 5; bzac(-) and phen for 6). The reduction of the V(IV) complexes was monitored by GC-MS and (1)H NMR spectroscopy. Both one- and two-dimensional (2D COSY and 2D EXSY) (1)H NMR techniques were used to assign the observed (1)H NMR resonances of 1-6 in CD(2)Cl(2) or CDCl(3) solution. It appeared that in solution these V(III) complexes form two isomers which are in equilibrium: cis-[V(III)Cl(2)(L(OO))(L(NN))] <==> trans-[V(III)Cl(2)(L(OO))(L(NN))]. 2D EXSY cross-peaks were clearly observed between bipy- and acac-hydrogen atoms of the two geometrical isomers of 1-3 as well as between bipy and acac(-) protons of the cis isomer, indicating a dynamic process that corresponds to cis-trans isomerization and a cis-cis racemization. The thermodynamic and kinetic parameters of the equilibrium between these two isomers were calculated for compounds 1 and 2 by using variable temperature (VT) NMR data. Both cis-trans isomerization and cis-cis racemization processes probably proceed with an intramolecular twist mechanism involving a trigonal prismatic transition state. Density functional calculations (DFT) also indicated such a rearrangement mechanism.     

Synthesis and Spectroscopic Characterizations of an Insulinomimetic Peroxovanadate Complex in Aqueous Solution

The reaction system of diperoxooxalatovanadate {K_3 [VO (O_2)_2-(C_2O_4)]·H_2O, bpV(Oxa)} and imidazole was studied in anaqueous solution by 1D multinuclear (~1H, ~(13)C and ~(51)V) NMR,2D NMR diffusion ordered spectroscopy (DOSY), and variabletemperature NMR techniques. It was shown that DOSY was auseful tool for the study of a mixture. All of the ~1H and ~(13)CNMR signals of the peroxovanadate (V) complexes were as-     

Synthesis and Characterization of Six-Coordinate Nitrido Complexes of Vanadium(V), Chromium(V), and Manganese(V). Isolation of a Dinuclear, Mixed-Valent &mgr;-Nitrido Chromium(III)/Chromium(V) Species

Photolysis of a series of octahedral monoazido complexes of the type [LM(III)(didentate ligand)(N(3))](n)(+)X(n) of vanadium(III), chromium(III), and manganese(III) in the solid state or in solution yields quantitatively the corresponding six-coordinate nitrido complexes [LM(V)(didentate ligand)(N)](n)(+)X(n) and 1 equiv of dinitrogen. L represents the macrocycle 1,4,7-triazacyclononane or its N-methylated derivative (L'), the didentate ligands are pentane-2,4-dionate (acac), 2,2,6,6-tetramethylheptane-3,5-dionate (tacac), picolinate (pic), phenanthroline (phen), and oxalate (ox), and X(-) represents perchlorate or hexafluorophosphate. The following nitrido complexes were prepared: [LV(V)(N)(acac)](ClO(4)) (6), [LCr(V)(N)(acac)](ClO(4)) (13), [LCr(V)(N)(tacac)](ClO(4)) (14), [LCr(V)(N)(pic)](ClO(4)) (15), [LCr(V)(N)(phen)](ClO(4))(2) (16), [LCr(V)(N)(ox)] (19), [L'Mn(V)(N)(acac)]PF(6) (21). Photolysis of [LCr(III)(N(3))(ox)] (17) in the solid state produces the &mgr;-nitrido-bridged mixed-valent species [L(2)Cr(2)(ox)(2)(&mgr;-N)](N(3)) (18). The structures of the precursor complex [L'Mn(acac)(N(3))]BPh(4) (20), of 13, and of [L'Mn(V)(N)(acac)]BPh(4) (21) have been determined by X-ray crystallography. Complex 13 crystallizes in the orthorhombic space group Pnma, with cell constants a = 27.187(5) ?, b = 9.228(2) ?, c = 7.070(1) ?, V = 1773.7(6) ?(3), and Z = 4; complex 20 crystallizes in the triclinic space group P&onemacr; with a = 14.769(5) ?, b = 16.83(1) ?, c = 16.96(1) ?, alpha = 108.19(5) degrees, beta = 105.06(4) degrees, gamma = 99.78(4) degrees, V = 3719(2) ?(3), and Z = 4; and complex 21 crystallizes in the monoclinic space group P2(1)/n with a = 10.443(3) ?, b = 16.035(4) ?, c = 21.463(5) ?, beta = 95.76(1) degrees, V = 3575.9(14) ?(3), and Z = 4. The Cr(V)&tbd1;N and Mn(V)&tbd1;N distances are short at 1.575(9) and 1.518(4) ?, respectively, and indicate a metal-to-nitrogen triple bond.     

咪唑类配体与双过氧钒配合物相互作用的NMR研究

为探讨咪唑环上取代基团对反应平衡的影响, 在模拟生理条件(0.15 mol·L-1 NaCl溶液)下, 应用多核(1H、13C和51V)、扩散排序谱(DOSY)以及变温NMR等谱学技术研究双过氧钒配合物NH4[OV(O2)2{2-(2’-Pyri-dine)-Imidazole}]·4H2O(简写为bpV(Imi-Py))和咪唑类配体(咪唑、2-甲基鄄咪唑、4-甲基-咪唑和组氨酸)的相互作用, 其从强到弱的顺序为咪唑≈4-甲基-咪唑>2-甲基-咪唑>组氨酸. 研究结果表明, 咪唑环上取代基团空间位阻对反应平衡产生较大影响,同时竞争配位的结果导致新的6 配位过氧物种[OV(O2)2L]-(L 为咪唑类配体)的生成, 当配体为4-甲基-咪唑和组氨酸时, 生成的则是一对异构体.     

新的稀土Eu,Tb(Ⅲ)β-二酮三元配合物的合成与光谱性质

采用Claisen缩合反应合成了一种β-二酮1-(4-氨基苯)-3-苯基丙烷-1,3-二酮(L:C15H13NO2),以元素分析和1H NMR谱确定了其组成,核磁和红外分析结果表明L主要以烯醇式存在。以L为第一配体,分别以邻菲罗啉(phen),2,2’-联吡啶(bipy)为第二配体,合成了新的稀土Eu,Tb(Ⅲ)三元配合物。通过元素分析、红外光谱、紫外光谱、磷光光谱和荧光光谱对合成的配合物进行了表征。荧光光谱表明:稀土铽配合物的发光性能优于稀土铕配合物,进一步研究表明配体L与Tb3+间能级差较匹配,分子内传能效率高;phen对配合物的荧光敏化效果优于bipy,表明第二配体的刚性和共轭性越大,配合物的发光性能越好。     

Designing molecular bistability in ruthenium dimethyl sulfoxide complexes

Compounds of the type [Ru(tpy)(L2)(dmso)](z+) (tpy is 2,2':6',2' '-terpyridine; L2 can be 2,2'-bipyridine (bpy), N,N,N',N'-tetramethylethylenediamine (tmen), 2-pyridine carboxylate (pic), acetylacetonate (acac), malonate (mal), or oxalate (ox)) have been studied by X-ray crystallography, electrochemistry, NMR, IR, and UV-vis spectroscopy. When L2 is bpy, tmen, or pic, the dmso ligand can be intramolecularly isomerized either electrochemically or photochemically. Isomerization is not observed when L2 is acac, mal, or ox. Isomerization results in a drastic change in the absorption spectrum, as well as in the voltammetry. Absorption maxima shift by 3470 (419-490 nm), 4775 (421-527 nm), and 4440 cm(-)(1) (429-530 nm) for the bpy, pic, and tmen complexes, respectively. Reduction potentials for S-bonded and O-bonded complexes differ by 0.57, 0.75, and 0.62 V for the bpy, pic, and tmen complexes, respectively. Quantum yields of isomerization (phi(S)(-->)(O)) were determined for the bpy (0.024 +/- 1), pic (0.25 +/- 1), and tmen (0.007 +/- 1) complexes. In comparison of these data to photosubstitution quantum yields, it appears that the isomerization mechanism does not involve the ligand field states. This result is surprising given the importance of these states in the photochemistry of ruthenium and osmium polypyridine complexes. These results and details of the mechanism are discussed.     

Spectroscopic studies on the interactions between a bioactive diperoxovanadate complex and pyridine

Interactions between a bioactive diperoxovanadate complex K3[OV(O2)2(C2O4)].H2O and pyridine in solution were studied by 2D NMR diffusion ordered spectroscopy (DOSY) as well as 1D 1H, 13C, 14N, and 51V NMR, variable temperature 1H NMR and spin-lattice relaxation time. Competitive coordination between C2O(4)(2-) and pyridine to [OV(O2)(2)](-) were observed in solution. A new species [OV(O2)2(Py)](-) was formed and its NMR data were reported for the first time. The experimental results indicated that both of the vanadium atom in species [OV(O2)2(C2O4)](3-) and [OV(O2)2(Py)](-) are six coordinated in solution. The conclusion was further supported by the results of ESI-MS. The newly-formed species is stable under the condition of near physiological pH value.     

Synthesis and preliminary DNA-binding studies of diimineplatinum(II) complexes containing 3- or 4-pyridineboronic acid

A series of platinum(II) complexes of the type [Pt(NN)(pyB)2](NO3)2 (NN = bipy, phen; pyB = 3- or 4-pyridineboronic acid) were successfully prepared and fully characterised by 1D- and 2D-multinuclear NMR spectroscopy and ESI-MS. Using VT 1H NMR spectroscopy, rotational isomers for [Pt(NN)(3-pyB)2](NO3)2 were identified and the free energies of activation for rotation of 3-pyB about the Pt-N bond were determined to be DeltaG++310) = 69.2 +/- 0.1 kJ mol(-1) and DeltaG++(305) = 66.0 +/- 0.1 kJ mol(-1) for [Pt(bipy)(3-pyB)2](NO3)2 and [Pt(phen)(3-pyB)2](NO3)2, respectively. The 3- and 4-pyB ligands readily deboronate in boiling H2O to afford [Pt(NN)(py)2](NO3)2; the structure of [Pt(phen)(py)2](2+) (as its PF6- salt) was confirmed by X-ray crystallography. Preliminary thermal denaturation studies revealed only minimal interactions between [Pt(NN)(pyB)2](NO3)2 and calf-thymus DNA and is attributed to hydroxylation of the boronic acid groups at pH 7.4 to afford the corresponding zwitterionic boronate species. This was confirmed by means of variable pH 1H and 11B{1H} NMR spectroscopy.     

Syntheses,Characterization, and Luminescence Properties of Three Coordination Complexes with Sulfonate-Phenol Anions and Trivalent Metal Ions

Russian Journal of General Chemistry - A dinuclear Tb complex, Tb2(H2L)3(phen)2 (1), and two similar N-donor coordination complexes, Fe(phen)3·HL (2), Fe(bipy)3·HL·5H2O (3) (Na2H2L =...     

Synthesis,characterization and cyclic voltammetric studies of monopicolinate complexes of ruthenium(II)

Summary Two stable monopicolinate complexes of ruthenium(II), [Ru(bipy)₂(pic)]ClO₄ and [Ru(pap)₂(pic)]ClO₄ [bipy = 2,2-bipyridine, pic = picolinate anion, pap = 2-(phenylazo)-pyridine], were prepared and characterized. The complexes are diamagnetic and behave as 1:1 electrolytes in MeCN solution. In the i.r. spectra, they show characteristic vibrations of bipy or pap, pic and ClO _inf4 ^p– . In MeCN solution, both complexes display three intense absorption bands in the visible region, which have been assigned to metal-to-ligand charge-transfer transitions. Each complex shows a reversible ruthenium(II)-ruthenium(III) oxidation in MeCN, the formal potential (E _inf298 ^p0 ) being 0.75 V versus a saturated calomel reference electrode (SCE) for [Ru-(bipy)₂(pic)]⁺ and 1.44 V versus SCE for [Ru(pap)₂(pic)]⁺. Multiple reductions of the coordinated bipy and pap ligands have also been observed.Author to whom all correspondence should be directed.     

Iron(III) mixed-ligand complexes: Synthesis,characterization and crystal structure determination of iron(III) hetero-ligand complexes containing 1,10-phenanthroline, 2,2′-bipyridine,chloride and dimethyl sulfoxide, [Fe(phen)Cl3(DMSO)] and [Fe(bipy)Cl3(DMSO)]

Treatment of [Fe(bipy)Cl₄][bipy · H] (1) and [Fe(phen)Cl₄][phen · H] (3) (where bipy is 2,2′-bipyridine and phen is 1,10-phenanthroline) with dimethyl sulfoxide in methanolic solution produced [Fe(bipy)Cl₃(DMSO)] (2) and [Fe(phen)Cl₃(DMSO)] (4) (where DMSO is dimethyl sulfoxide), respectively. The resulting complexes were characterized by elemental analysis, IR, UV–Vis and ¹H NMR spectroscopies and by the X-ray diffraction method. These complexes are high spin with a spin multiplicity of 6.     

Spectroscopic and theoretical study on the interaction between diperoxovanadate and oxazole

Detailed investigations were carried out to explore the interaction systems of NH(4)VO(3)/H(2)O(2)/oxazole in aqueous solution under physiological conditions by a combined use of multinuclear NMR ((1)H, (13)C, (14)N and (51)V), diffusion ordered spectroscopy (DOSY), variable temperature NMR, electrospray ionization mass spectrometry (ESI-MS), spin-lattice relaxation and density functional calculations. The results indicated the formation of a new peroxovanadate species [OV(O(2))(2)(oxazole)](-) with oxazole coordinating to vanadium through nitrogen atom. The solution structure of the new species was predicted from theoretical calculations.     

From model compounds to protein binding: syntheses, characterizations and fluorescence studies of [RuII(bipy)(terpy)L]2+ complexes (bipy = 2,2'-bipyridine; terpy = 2,2':6',2''-terpyridine; L = imidazole, pyrazole and derivatives, cytochrome c)

Compounds [RuII(bipy)(terpy)L](PF6)2 with bipy = 2,2'-bipyridine, terpy = 2,2':6',2"-terpyridine, L = H2O, imidazole (imi), 4-methylimidazole, 2-methylimidazole, benzimidazole, 4,5-diphenylimidazole, indazole, pyrazole, 3-methylpyrazole have been synthesized and characterized by 1H NMR, ESI-MS and UV/Vis (in CH3CN and H2O). For L = H2O, imidazole, 4,5-diphenylimidazole and indazole the X-ray structures of the complexes have been determined with the crystal packing featuring only few intermolecular C-H...pi or pi-pi interactions due to the separating action of the PF6-anions. Complexes with L = imidazole and 4-methylimidazole exhibit a fluorescence emission with a maximum at 662 and 667 nm, respectively (lambdaexc= 475 nm, solvent CH3CN or H2O). The substitution of the aqua ligand in [Ru(bipy)(terpy)(H2O)]2+ in aqueous solution by imidazole to give [Ru(bipy)(terpy)(imi)]2+ is fastest at a pH of 8.5 (as followed by the increase in emission intensity). Coupling of the [Ru(bipy)(terpy)]2+ fragment to cytochrome c(Yeast iso-1) starting from the Ru-aqua complex was successful at 35 degrees C and pH 7.0 after 5 d under argon in the dark. The [Ru(bipy)(terpy)(cyt c)]-product was characterized by UV/Vis, emission and mass spectrometry. The location where the [Ru(bipy)(terpy)] complex was coupled to the protein was identified as His44 (corresponding to His39 in other numbering schemes) using digestion of the Ru-coupled protein by trypsin and analysis of the tryptic peptides by HPLC-high resolution MS.     

Kinetics and mechanistic studies of anticarcinogenic bisperoxovanadium(V) compounds: ligand substitution reactions at physiological pH and relevance to DNA interactions

Bisperoxovanadium(V) compounds with bidentate ligands have shown tumor growth inhibition by cleaving DNA. The kinetics and mechanisms of ligand substitution reactions of two bisperoxovanadium(V) compounds [VO(O(2))(2)(bpy)](-) (bpVbpy) and [VO(O(2))(2)(phen)](-) (bpVphen) with entering ligands picolinic acid (pic) and dipicolinic acid (dipic) at physiological pH are reported, and its relevance to their DNA-cleavage activities are discussed. The products of the ligand substitution reactions with pic and dipic are the monoperoxo complexes [VO(O(2))(pic)(2)](-) and [VO(O(2))(dipic)(H(2)O)](-), respectively. (51)V NMR experiments indicate that bpVphen is substantially more inert in aqueous solution than bpVbpy. As a result, bpVbpy is more prone to ligand substitution and subsequent conversion to monoperoxo species. The rate of reaction for bpVbpy was faster than that of bpVphen by an order of magnitude, indicating that the ancillary ligand plays an important role in ligand substitution reactions. The ligand substitution reactions of bpVbpy feature first-order dependence on both [pic](T) and [dipic](T) whereas the substitution kinetics of bpVphen feature saturation behavior with dipic. The substitution reactions of both bpVbpy and bpVphen with pic showed first-order dependence on [H(+)] whereas no acid dependence was observed for the reactions with dipic. Hydrogen peroxide was determined to be a competitive inhibitor with respect to dipic. The ligand substitution reaction mechanisms and the rate laws consistent with these results are presented. The substitution reactions with pic and dipic proceed through different mechanisms; the substitution reactions with dipic proceed via solvolysis as the first step in the mechanisms whereas the reactions with pic bypass solvolysis to go through a mixed ligand monoperoxo vanadium intermediate.     

N-heterocycle chelated oxomolybdenum(VI and V) complexes with bidentate citrate

A 1,10-phenanthroline (phen) chelated molybdenum(VI) citrate, [(MoO2)2O(H2cit)(phen)(H2O)2] x H2O (1) (H4cit = citric acid), is isolated from the reaction of citric acid, ammonium molybdate and phen in acidic media (pH 0.5-1.0). A citrato oxomolybdenum(V) complex, [(MoO)2O(H2cit)2(bpy)2] x 4H2O (2), is synthesized by the reduction of citrato molybdate with hydrazine hydrochloride in the presence of 2,2'-bipyridine (bpy), and a monomeric molybdenum(VI) citrate [MoO2(H2cit)(bpy)] x H2O (6) is also isolated and characterized structurally. The citrate ligand in the three neutral compounds uses the alpha-alkoxy and alpha-carboxy groups to chelate as a bidentate leaving the two beta-carboxylic acid groups free, that is different from the tridentate chelated mode in the citrato molybdate(VI and V) complexes. 1 and in solution show obvious dissociation based on 13C NMR studies.